Related Experiment Videos
Regulation of the Ras signalling network
1Ludwig Institute for Cancer Research, Melbourne, Australia.
Summary
Mutated Ras proteins drive cancer by constantly signaling cells to grow. Specific molecular fragments can block this Ras signaling, offering a new way to treat Ras-driven tumors, which are common in many cancers.
Area of Science:
- Molecular Biology
- Cell Signaling
- Oncology
Background:
- Cytokines like EGF and PDGF regulate cell growth via Ras signaling.
- Ras mutations lead to constitutive activation, bypassing normal growth control.
- Ras activation involves GDP-bound (D-Ras) to GTP-bound (T-Ras) conversion, initiating downstream kinase cascades.
Purpose of the Study:
- To investigate the mechanism of Ras-mediated mitogenesis.
- To identify potential therapeutic agents targeting Ras activation.
- To explore the role of Ras modulators in controlling tumor proliferation.
Main Methods:
- Studied the signal cascade initiated by Ras activation.
- Investigated the function of Ras modulators like GAP1 and NF1.
- Assessed the inhibitory effects of specific molecular fragments on T-Ras activity.
Main Results:
- Ras activation leads to the formation of T-Ras, which activates kinases like c-Raf-1 and MAP kinase.
- MAP kinase activation results in the upregulation of transcription factors (c-Jun, c-Myc, c-Fos) and elongation factor 4E.
- NF1 fragments and truncated c-Raf-1, c-Jun, c-Myc derivatives competitively inhibit T-Ras-activated mitogenesis.
Conclusions:
- Ras signaling is a critical pathway in cell proliferation and cancer development.
- Targeting T-Ras with specific inhibitors presents a promising therapeutic strategy.
- These findings offer potential for controlling proliferation in over 30% of human carcinomas associated with Ras mutations.